Secondary Logo

Share this article on:

Editorial introductions

Section Editor(s): Annesi-Maesano, Isabella; Cianferoni, Antonella; Werfel, Thomas; Torsten, Zuberbier; Leonard, Bielory; Abraham, Solomon

Current Opinion in Allergy and Clinical Immunology: October 2015 - Volume 15 - Issue 5 - p v–vii
doi: 10.1097/ACI.0000000000000211
EDITORIAL INTRODUCTIONS

Current Opinion in Allergy and Clinical Immunology was launched in 2001. It is one of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The fields of allergy and clinical immunology are divided into 14 sections that are reviewed once a year. Each section is assigned a Section Editor, a leading authority in the area, who identifies the most important topics at that time. Here we are pleased to introduce the Journal's Section Editors for this issue.

Back to Top | Article Outline

SECTION EDITORS

Isabella Annesi-Maesano

Isabella Annesi-Maesano

Isabella Annesi-Maesano

Isabella Annesi-Maesano is Research Director at the French NIH (INSERM) and Professor of Environmental Epidemiology at Université Pierre and Marie Curie (UPMC) and Université Denis Diderot in Paris. Since 2006, she has headed the Department of Epidemiology of Allergic and Respiratory diseases (EPAR) at the Institute Pierre Louis of Epidemiology and Public Health of INSERM and Université Pierre and Marie Curie (UPMC) in Paris. Her research includes the explanation of the development of allergic and respiratory diseases and their comorbidities (metabolic diseases, cardiovascular diseases, neurodevelopmental troubles etc.) through an exposomic approach. She is presently Principal Investigator and Coordinator of the FP7-ENV Health and Environment-wide Associations based on Large Population Surveys (http://www.health-eu.eu).

Dr Annesi-Maesano acted as a member of executive committees and programme and congresses committees of several medical societies (ERS, EAACI, IUATLD, ATS…).

She is a respiratory epidemiologist by training through a PhD, a DSc and a post-doc (Department of Public Health Sciences at St George's Hospital, London) in Epidemiology and Public Health. She graduated in Physics (Rome) and Medicine (Paris).

She is the authors of over 350 papers, reviews and chapters in peer-reviewed publications.

Presently, she is Associate Editor of 7 international journals and 1 national journal.

Back to Top | Article Outline

Antonella Cianferoni

Antonella Cianferoni

Antonella Cianferoni

Dr Cianferoni is an ABAI certified, practicing pediatric allergist with a special clinical and research interest in food allergy and eosinophilic esophagitis. She did her medical school and pediatric training at the University of Florence, Italy and completed her US training in general pediatrics at the Children's Hospital of Philadelphia and her allergy and Immunology Training at Boston Children's Hospital, having previously completed a research fellowship at the Hopkins Allergy and Asthma Center. Since 2007 she has been an assistant professor of pediatrics at the University of Pennsylvania, Perelman School of Medicine, and she is an attending doctor in the Allergy and Immunology Division at Children's Hospital of Philadelphia (CHOP). She is the co-director of the FARE Food Allergy Center at CHOP and a member of the Center for Pediatric Eosinophilic Disorders (CPED) at CHOP. She is the secretary of the Basic And Clinical immunology Interest section for The American Academy of Allergy Asthma and Immunology (AAAAI) and a member of EoE interest group for European Academy of Allergy and Clinical Immunology (EAACI). Her research has been focused on understanding the role of invariant natural killer T cells, basophils and T cells in food allergy pathogenesis, genetics of eosinophilic esophagitis and transcription of cytokine in T cells. She has also clinically characterized many classic allergic diseases such as anaphylaxis and drug and venom allergy.

Back to Top | Article Outline

Thomas Werfel

Thomas Werfel

Thomas Werfel

Professor Werfel is an MD and spent four years as a post-doc in basic immunology before he began his residency at Hannover Medical School, Germany, in the Department of Dermatology. In 1994 he gained Board certification in Dermatology and Allergy and also has a Board membership in Immunology.

Since 2008 Professor Werfel has been Head of the Division of Immunodermatology and Allergy Research (Full Professorship) and in addition, the Vice Director of the Department of Dermatology and Allergy at Hannover Medical School.

Professor Werfel's research interests focus on chronic inflammatory skin diseases including atopic dermatitis (e.g. role of allergens, microbial antigens and autoantigens in atopic dermatitis, immunology of eczematous skin diseases, new therapeutical approaches in atopic dermatitis). He is currently a member of the Executive Committees of the European Society of Dermatological Research (ESDR), the European Academy of Allergy, Asthma and Clinical Immunology (EAACI) and is Vice President of the Society of Allergy and Clinical Immunology (DGAKI).

Since 1992 he has continuously received research grants from the ‘Deutsche Forschungsgemeinschaft’ (DFG) and various research foundations, and received several awards for his work in allergy and inflammation research.

Back to Top | Article Outline

Torsten Zuberbier

Torsten Zuberbier

Torsten Zuberbier

Prof Dr med. Dr h. c. Torsten Zuberbier is Managing Director at the Department of Dermatology, Venereology & Allergy, Charité - Universitätsmedizin Berlin, Germany, and holds an honorary doctorate from the University of Athens, Greece. Furthermore, Prof Zuberbier is the Secretary General of the Global Allergy and Asthma European Network (GA2LEN) - Network of Excellence as well as the spokesperson of the Allergie-Centrum-Charité in the Dermatology Clinic of the Charité in Berlin Mitte. Since 2003 Prof Zuberbier has been the Head of the European Centre for Allergy Research Foundation (ECARF), Berlin, Germany.

His career began in 1990 at the Virchow Clinics, Free University of Berlin, Germany, where in 1995 he became a senior physician at the Dept. of Dermatology. His clinical research focuses on urticaria, atopic eczema, inhalant and food allergies and allergic rhinitis. His research experience is in the domain of human mast cell differentiation and function as well as in clinical allergology with a focus on urticaria, food- and inhalant allergies. He has published more than 300 papers and he is a member of numerous scientific bodies including: the Editorial Board of the Journal of Clinical and Experimental Dermatology and the Journal der Deutschen Dermatologischen Gesellschaft (JDDG); the advisory board of Allergo Journal; the Executive Committee of the German Society for Allergy and Clinical Immunology; the Expert Commission ‘Novel Food’ of the German Federal Ministry of Consumer Protection, Executive Committee member of ARIA and member of the World Allergy Organisation Communications Council.

Prof Zuberbier was born in 1962 and lives with his family on the outskirts of Berlin, Germany.

Back to Top | Article Outline

Leonard Bielory

Leonard Bielory

Leonard Bielory

Dr Bielory attended Lehigh University in Bethlehem, Pennsylvania, USA, where he completed his B.S. in Engineering (Fundamental Science) and a Masters in Molecular Biology (1976); M.D. degree from Rutgers University (previously UMDNJ) - New Jersey Medical School, USA, (1976–1980); internal medicine training at the University of Maryland Hospital, USA; subspecialty training in allergy and immunology and diagnostic laboratory immunology at the National Institutes of Health (NIH), USA, as a medical staff fellow in the – National Heart, Lung and Blood Institute (NHLBI) and the National Institute of Allergy and Infectious Diseases (NIAID) where his research focus has been on the classic immune complex disorder – serum sickness. He was recruited back to his alma mater to direct the Division of Allergy and Immunology at the Rutgers University (previously UMDNJ) - New Jersey Medical School where he has been for 25 years as Professor of Medicine, Pediatrics and Ophthalmology and directed the only training program in Allergy and Immunology in the State of New Jersey for 20 years. He is presently appointed as a Research Professor to the Rutgers University Center of Environmental Prediction. He has consistently been selected as one of New Jersey and New York ‘Top Docs’ in the New Jersey and New York metropolitan area surveys for the past 20 years. He has published several hundred publications in peer-reviewed journals, presently serves as an Associate Editor of the Annals of Allergy, Asthma and Immunology journal, serves on several other editorial boards and as a reviewer for multiple journals. He continues to serve in various capacities in a variety of national organizations including as a member of the Board of Directors for the American College of Allergy, Asthma and Immunology (ACAAI), multiple committee chairs for various committees in the American Academy of Allergy, Asthma and Immunology (AAAAI) and ACAAI, World Allergy Organization, past Chairman of the NIH – National Heart, Lung and Blood Institute Raynaud's Treatment Trial; the program chairman for the ACAAI International Symposium on Complementary Interventions in Treatment of Asthma and Allergy; reviewer for the NIH National Center for Complementary and Alternative Medicine Centers (NCCAM) of Excellence for Research on Complementary and Alternative Medicine (CERC). He has been appointed by the Governor of New Jersey to sit on the Clean Air Council advisory to the New Jersey Department of Environmental Protection and is presently its chair of the recent annual public hearing on Climate Change. Dr Bielory has participated on two United States Pharmacopoeia (USP) Council of Experts Committees (Immunology as well as Respiratory and Allergy). He was an original member of the USP Medicare Model Formulary Committee mandated by the United Stated Congress. He is an international expert in inflammatory disorders of the anterior portion of the eye – especially various forms of ocular allergy and is a regional expert on pollen and climate change. He has successfully completed over 50 clinical research studies in asthma and allergic disorders. Active research focuses on new immune treatments for asthma and a rare disorder known as hereditary angioedema. He has been recently awarded an US Environmental Protection Agency grant as the Principal Investigator focusing on Climate and Allergic Airway Disease that has supported the March 2011 publication in Proceedings of the National Academy of Sciences on Climate Change and Ragweed Pollination with several other publications on climate change under review.

Back to Top | Article Outline

Abraham Solomon

Abraham Solomon

Abraham Solomon

Abraham (Avi) Solomon is an Associate Professor of Ophthalmology at the Department of Ophthalmology at Hadassah-Hebrew University Medical Center, Jerusalem, Israel. He was born in Tel-Aviv, Israel, and completed his MD degree at the University of Tel-Aviv School of Medicine. He performed his residency in Ophthalmology at the Department of Ophthalmology at Hadassah-Hebrew University Medical Center (1992–1997), followed by a fellowship in Cornea and External Eye Disease at Bascom Palmer Eye Institute, in Miami Florida (1998–2001). Prof Solomon has published 90 articles and reviews in peer-reviewed journals.

Prof Solomon is currently the Head of the Cornea Service at the Department of Ophthalmology at Hadassah-Hebrew University Medical Center, Jerusalem, Israel. He served as the Chairman of the Department of Optometry, Hadassah College Jerusalem (2003–2007); the head of the Teaching Program in Ophthalmology, the Hadassah-Hebrew University Faculty of Medicine (2007–2010); the chairman of the Israeli Cornea Society (2010–2012); and until recently as the Chairman of the Israeli Society for Vision and Eye Research (ISVER), which is an ARVO chapter affiliate (2012–2015).

Prof Solomon's main clinical expertise is in the area of Cornea and External Eye Diseases and Refractive Surgery. His main clinical and basic research interests are in the areas of ocular surface diseases and ocular surface reconstructive surgery, limbal stem cell deficiency, ocular surface inflammation and anti-inflammatory drug research, ocular allergic eye diseases and topical anti-allergic drug research.

Copyright © 2015 Wolters Kluwer Health, Inc. All rights reserved.